US 8288536
Kinase inhibitors
granted A61PA61P1/00A61P15/18
Quick answer
US patent 8288536 (Kinase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P1/00, A61P15/18, A61P17/06, A61P17/14